Trade

with

NeoGenomics Inc
(NASDAQ: NEO)
AdChoices
4.91
-0.04
-0.81%
After Hours :
4.91
0.00
0.00%

Open

4.91

Previous Close

4.95

Volume (Avg)

128.03k (327.13k)

Day's Range

4.80-4.98

52Wk Range

2.95-6.10

Market Cap.

246.36M

Dividend Rate ( Yield )

-

Beta

0.81

Shares Outstanding

50.17M

P/E Ratio (EPS)

123.46 (0.04)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Diagnostics & Research
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 66.47M

    • Net Income

    • 2.03M

    • Market Cap.

    • 246.36M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 2.88

    • PEG (Price/Earnings Growth) Ratio

    • 2.76

    • Beta

    • 0.81

    • Forward P/E

    • 57.80

    • Price/Sales

    • 3.54

    • Price/Book Value

    • 10.65

    • Price/Cash flow

    • 35.84

      • EBITDA

      • 7.59M

      • Return on Capital %

      • 5.46

      • Return on Equity %

      • 10.02

      • Return on Assets %

      • 5.46

      • Book Value/Share

      • 0.46

      • Shares Outstanding

      • 50.17M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 7.00

        • Credit Rating

        • -

        • Analysts

        • 3

        • EPS Estimate

        • 0.09

        • Cashflow Estimate

        • 0.21

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 32.50

          • 21.91

          • Net Income

            YTD/YTD (last year)

          • 3,027.70

          • -5.55

          • Net Income

            Q/Q (last year)

          • 0.40

          • 0.44

          • Sales (Revenue)

            5-Year Annual Average

          • 27.13

          • 47.82

          • Net Income

            5-Year Annual Average

          • -

          • 4.98

          • Dividends

            5-Year Annual Average

          • -

          • 5.31

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 48.99

            • 42.70

            • Pre-Tax Margin

            • 3.17

            • 11.63

            • Net Profit Margin

            • 2.88

            • 9.55

            • Average Gross Margin

              5-Year Annual Average

            • 47.00

            • 43.76

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 11.34

            • Average Net Profit Margin

              5-Year Annual Average

            • -3.40

            • 52.13B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.20

              • 0.62

              • Current Ratio

              • 1.84

              • 1.23

              • Quick Ratio

              • 1.56

              • 0.76

              • Interest Coverage

              • -

              • 5.98

              • Leverage Ratio

              • 1.89

              • 2.16

              • Book Value/Share

              • 0.46

              • 14.94

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 117.65

                • 33.22

                • P/E Ratio 5-Year High

                • 152.72

                • 325.07

                • P/E Ratio 5-Year Low

                • 23.78

                • 154.73

                • Price/Sales Ratio

                • 3.39

                • 2.34

                • Price/Book Value

                • 10.19

                • 3.04

                • Price/Cash Flow Ratio

                • 35.84

                • 19.08

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • 10.02

                        (-30.00)

                      • 9.34

                        (9.80)

                      • Return on Assets %

                        (5-Year Average)

                      • 5.46

                        (-9.60)

                      • 4.63

                        (5.44)

                      • Return on Capital %

                        (5-Year Average)

                      • 6.99

                        (-8.20)

                      • 5.73

                        (6.77)

                      • Income/Employee

                      • 6.77k

                      • 17.17k

                      • Inventory Turnover

                      • 17.35

                      • 5.07

                      • Asset Turnover

                      • 1.90

                      • 0.48

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      3.17M
                      Operating Margin
                      4.78
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      35.84
                      Ownership

                      Institutional Ownership

                      82.58%

                      Top 10 Institutions

                      60.00%

                      Mutual Fund Ownership

                      12.88%

                      Float

                      78.23%

                      5% / Insider Ownership

                      2.38%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard US Discoveries Fund

                      •  

                        1,254,962

                      • -0.29

                      • 2.51

                      • Vanguard Total Stock Mkt Idx

                      •  

                        785,663

                      • 0.00

                      • 1.57

                      • Gabelli Healthcare & Wellness Trust

                      •  

                        450,000

                      • 63.64

                      • 0.90

                      • TFS Market Neutral Fund

                      •  

                        335,512

                      • 92.72

                      • 0.67

                      • Driehaus Micro Cap Growth Fund

                      •  

                        320,404

                      • 104.03

                      • 0.64

                      • Vanguard Extended Market Index Fund

                      •  

                        305,427

                      • 4.01

                      • 0.61

                      • VAM Funds (Lux) – US Micro Cap Growth

                      •  

                        279,604

                      • 106.32

                      • 0.56

                      • AllianzGI Ultra Micro Cap Fund

                      •  

                        186,500

                      • 45.90

                      • 0.37

                      • TETON Westwood Mighty Mites Fund

                      •  

                        161,407

                      • 125.00

                      • 0.32

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • RMB Capital Management, LLC

                      •  

                        4,042,010

                      • 0.00%

                      • 8.08

                      • Cortina Asset Management LLC

                      •  

                        2,809,409

                      • -2.27%

                      • 5.62

                      • GROW Partners LLC

                      •  

                        2,737,800

                      • -17.77%

                      • 5.47

                      • Thomson Horstmann & Bryant, Inc.

                      •  

                        2,053,054

                      • -7.60%

                      • 4.09

                      • First Light Asset Management, LLC

                      •  

                        2,037,528

                      • +38.69%

                      • 4.07

                      • Granahan Investment Management Inc..

                      •  

                        1,337,115

                      • +4.80%

                      • 2.66

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Diagnostics & Research

                      Type

                      Speculative Growth

                      Style

                      Small Growth

                      NeoGenomics, Inc., operates a network of cancer-focused testing laboratories in Ft. Myers and Tampa, Florida; Irvine, California; and Nashville, and Tennessee. Its testing services include: Cytogenetics testing - the study of normal ...moreand abnormal chromosomes and their relationship to disease. Cytogenetic studies are often utilized to answer diagnostic, prognostic and predictive questions in the treatment of hematological malignancies and solid tumors; Fluorescence In-Situ Hybridization (FISH) testing - a branch of cancer genetics that focuses on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes. FISH helps bridge abnormality detection between the chromosomal and DNA sequence levels; Flow cytometry testing - a rapid way to measure the characteristics of ...morecell populations. Cells from peripheral blood, bone marrow aspirate, lymph nodes, and other areas are labeled with selective fluorescent antibodies and quantified according to their surface antigens. These fluorescent antibodies bind to specific cell surface antigens and are used to identify malignant cell populations. Flow cytometry is typically performed in conjunction with morphology testing which looks at smears on glass slides for abnormal cell populations; Immunohistochemistry (IHC) testing - the process of identifying cell proteins in a tissue section utilizing the principle of antibodies binding specifically to antigens. Specific surface cytoplasmic or nuclear markers are characteristic of cellular events such as proliferation or cell death (apoptosis). IHC is also widely used to understand the distribution and localization of differentially expressed proteins; and Molecular testing - a rapidly emerging cancer diagnostic tool focusing on the analysis of DNA and RNA, as well as the structure and function of genes at the molecular level. Molecular testing employs multiple technologies including bi-directional Sanger sequencing analysis, DNA fragment length analysis, real-time polymerase chain reaction (RT-PCR) RNA analysis and Next-Generation sequencing. The Company has one reportable operating segment that delivers testing services to hospitals, pathologists, oncologists, other clinicians and researchers. The Company’s competitors in the United States are numerous and include major national medical testing laboratories, hospital laboratories and in-house physician laboratories. The Company orders its laboratory and research supplies from large national laboratory supply companies such as Abbott Laboratories, Fisher Scientific, Life Technologies, Metasystems, Invitrogen, Cardinal Health, Ventana and Beckman Coulter. The laboratory business is subject to extensive governmental regulation at the federal, state and local levels.lessless

                      Key People

                      Douglas M. VanOort

                      CEO/Chairman of the Board/Director

                      Dr. Michael T. Dent,M.D.

                      Founder/Director

                      Mr. George Cardoza

                      CFO

                      Mr. Steven A. Ross

                      Chief Information Officer

                      Steven C. Jones

                      Director/Executive VP, Divisional/Other Executive Officer

                      • NeoGenomics Inc

                      • 12701 Commonwealth Drive

                      • Fort Myers, FL 33913

                      • USA.Map

                      • Phone: +1 239 768-0600

                      • Fax: +1 239 690-4237

                      • neogenomics.com

                      Incorporated

                      2001

                      Employees

                      315

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: